CUSIP: 34960Q109
Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,185,993
-
Share change
-
+2,323,656
-
Total reported value
-
$17,362,233
-
Price per share
-
$1.89
-
Number of holders
-
53
-
Value change
-
+$4,224,635
-
Number of buys
-
27
-
Number of sells
-
18
Quarterly Holders Quick Answers
What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2020
-
Previous quarter:
Q4 2019
Recent filing periods for CUSIP 34960Q109:
Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) as of Q1 2020
As of 31 Mar 2020,
FORTRESS BIOTECH INC - COM (FBIO) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,185,993 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, CPWM, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, and SHIKIAR ASSET MANAGEMENT INC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.